Chronic Daily Headache in Korea: Prevalence, Clinical Characteristics, Medical Consultation and Management
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background and Purpose Chronic daily headache (CDH) is a commonly reported reasonfor visiting hospital neurology departments, but its prevalence, clinical characteristics, andmanagement have not been well documented in Korea. The objective of this study was to characterize the 1-year prevalence, clinical characteristics, medical consultations, and treatment forCDH in Korea. Methods The Korean Headache Survey (KHS) is a nationwide descriptive survey of 1507Korean adults aged between 19 and 69 years. The KHS investigated headache characteristics,sociodemographics, and headache-related disability using a structured interview. We used theKHS data for this study. Results The 1-year prevalence of CDH was 1.8% (95% confidence interval, 1.1–2.5%), and25.7% of the subjects with CDH met the criteria for medication overuse. Two-thirds (66.7%) ofCDH subjects were classified as having chronic migraine, and approximately half of the CDHsubjects (48.1%) reported that their headaches either substantially or severely affected theirquality of life. Less than half (40.7%) of the subjects with CDH reported having consulted adoctor for their headaches and 40.7% had not received treatment for their headaches during theprevious year. Conclusions The prevalence of CDH was 1.8% and medication overuse was associated withone-quarter of CDH cases in Korea. Many subjects with CDH do not seek medical consultation anddo not receive appropriate treatment for their headaches.
Abstract
Background and Purpose Chronic daily headache (CDH) is a commonly reported reasonfor visiting hospital neurology departments, but its prevalence, clinical characteristics, andmanagement have not been well documented in Korea. The objective of this study was to characterize the 1-year prevalence, clinical characteristics, medical consultations, and treatment forCDH in Korea. Methods The Korean Headache Survey (KHS) is a nationwide descriptive survey of 1507Korean adults aged between 19 and 69 years. The KHS investigated headache characteristics,sociodemographics, and headache-related disability using a structured interview. We used theKHS data for this study. Results The 1-year prevalence of CDH was 1.8% (95% confidence interval, 1.1–2.5%), and25.7% of the subjects with CDH met the criteria for medication overuse. Two-thirds (66.7%) ofCDH subjects were classified as having chronic migraine, and approximately half of the CDHsubjects (48.1%) reported that their headaches either substantially or severely affected theirquality of life. Less than half (40.7%) of the subjects with CDH reported having consulted adoctor for their headaches and 40.7% had not received treatment for their headaches during theprevious year. Conclusions The prevalence of CDH was 1.8% and medication overuse was associated withone-quarter of CDH cases in Korea. Many subjects with CDH do not seek medical consultation anddo not receive appropriate treatment for their headaches.
참고문헌 (52)
- Mathew NT, "Chronic refractory headache", Neurology, 43(6 Suppl 3), pp.S26~S33 (1993)
- Pascual J, "Epidemiology of chronic daily headache", Curr Pain Headache Rep, 5, pp.529~536 (2001)
- Buse DC, "Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study", Headache, 52, pp.1456~1470 (2012)
- Lantéri-Minet M, "Prevalence and description of chronic daily headache in the general population in France", Pain, 102, pp.143~149 (2003)
- Hagen K, "Prevalence of migraine and non-migrainous headache--head-HUNT, a large population-based study", Cephalalgia, 20, pp.900~906 (2000)
- Queiroz LP, "Chronic daily headache in Brazil: a nationwide populationbased study", Cephalalgia, 28, pp.1264~1269 (2008)
- Rasmussen BK, "Epidemiology of headache in a general population--a prevalence study", J Clin Epidemiol, 44, pp.1147~1157 (1991)
- Dodick DW, "OnabotulinumtoxinA for treatment of chronic migraine:pooled results from the double-blind, randomized, placebocontrolled phases of the PREEMPT clinical program", Headache, 50, pp.921~936 (2010)
- Headache Classification Committee, "New appendix criteria open for a broader concept of chronic migraine", Cephalalgia, 26, pp.742~746 (2006)
- Headache Classification Committee of the International Headache Society (IHS), "The International Classification of Headache Disorders, 3rd edition (beta version)", Cephalalgia, 33, pp.629~808 (2013)
- 김병건, "Prevalence and Impact of Migraine and Tension-Type Headache in Korea", Journal of Clinical Neurology, 8(3), pp.204~211 (2012), 대한신경과학회
- "International Ethical Guidelines for Biomedical Research Involving Human Subjects" (2002)[URL]
- "Korean Statistical Information Service" (2009)[URL]
- 윤연옥, "통계청 가구부문 조사의 표본설계", 조사연구, 5(1), pp.103~130 (2004), 한국조사연구학회
- Kosinski M, "A six-item short-form survey for measuring headache impact: the HIT-6", Qual Life Res, 12, pp.963~974 (2003)
- 주민경, "한국어판 두통영향 검사(Headache Impact Test-6)의 타당도 및 신뢰도 조사", 대한신경과학회지, 27(1), pp.1~6 (2009), 대한신경과학회
- Alders EE, "A community-based prevalence study on headache in Malaysia", Headache, 36, pp.379~384 (1996)
- Ho KH, "Headache characteristics and race in Singapore: results of a randomized national survey", Headache, 41, pp.279~284 (2001)
- Lu SR, "Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors", Cephalalgia, 21, pp.980~986 (2001)
- Rao GN, "The burden of headache disorders in India: methodology and questionnaire validation for a community-based survey in Karnataka State", J Headache Pain, 13, pp.543~550 (2012)
- Wang SJ, "Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up", Neurology, 54, pp.314~319 (2000)
- Yu S, "The prevalence and burden of primary headaches in China: a population-based doorto-door survey", Headache, 52, pp.582~591 (2012)
- Bigal ME, "Field testing alternative criteria for chronic migraine", Cephalalgia, 26, pp.477~482 (2006)
- Grande RB, "Prevalence of primary chronic headache in a population-based sample of 30- to 44-year-old persons. The Akershus study of chronic headache", Neuroepidemiology, 30, pp.76~83 (2008)
- Katsarava Z, "Primary headache disorders in the Republic of Georgia: prevalence and risk factors", Neurology, 73, pp.1796~1803 (2009)
- Scher AI, "Prevalence of frequent headache in a population sample", Headache, 38, pp.497~506 (1998)
- Bigal ME, "Obesity is a risk factor for transformed migraine but not chronic tension-type headache", Neurology, 67, pp.252~257 (2006)
- Stark RJ, "Chronic migraine and chronic daily headache in the Asia-Pacific region:a systematic review", Cephalalgia, 33, pp.266~283 (2013)
- Stewart WF, "Variation in migraine prevalence by race", Neurology, 47, pp.52~59 (1996)
- Lasch KE, "Culture and pain", Pain: Clin Updates, 10, pp.1~9 (2002)
- Lipton RB, "Patterns of health care utilization for migraine in England and in the United States", Neurology, 60, pp.441~448 (2003)
- Scher AI, "Factors associated with the onset and remission of chronic daily headache in a populationbased study", Pain, 106, pp.81~89 (2003)
- Castillo J, "Kaplan Award 1998. Epidemiology of chronic daily headache in the general population", Headache, 39, pp.190~196 (1999)
- Bigal ME, "Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment", Neurology, 71, pp.559~566 (2008)
- 서경임, "Differences in Clinical Features and Disability according to the Frequency of Medication Use in Patients with Chronic Migraine", Journal of Clinical Neurology, 8(3), pp.198~203 (2012), 대한신경과학회
- Bigal ME, "Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache", Cephalalgia, 22, pp.432~438 (2002)
- D’Amico D, "Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials", Neurol Sci, 31(31Suppl 1), pp.S23~S28 (2010)
- Diener HC, "OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial", Cephalalgia, 30, pp.804~814 (2010)
- Silberstein SD, "Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial", Headache, 47, pp.170~180 (2007)
- Yurekli VA, "The effect of sodium valproate on chronic daily headache and its subgroups", J Headache Pain, 9, pp.37~41 (2008)
- Diener HC, "Chronic migraine--classification, characteristics and treatment", Nat Rev Neurol, 8, pp.162~171 (2012)
- Bigal ME, "Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine", Headache, 43, pp.336~342 (2003)
- D’Amico D, "Disability in chronic daily headache: state of the art and future directions", Neurol Sci, 32(Suppl 1), pp.S71~S76 (2011)
- Wang SJ, "Epidemiology of migraine and other types of headache in Asia", Curr Neurol Neurosci Rep, 3, pp.104~108 (2003)
- Roh JK, "Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea", Headache, 38, pp.356~365 (1998)
- Rasmussen BK, "Questionnaire versus clinical interview in the diagnosis of headache", Headache, 31, pp.290~295 (1991)
- Headache Classification Subcommittee of the International Headache Society, "The International Classification of Headache Disorders: 2nd edition", Cephalalgia, 24(Suppl 1), pp.9~160 (2004)
- Göbel H, "The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society", Cephalalgia, 14, pp.97~106 (1994)
- Lavados PM, "Epidemiology of tension-type headache in Santiago, Chile: a prevalence study", Cephalalgia, 18, pp.552~558 (1998)
- Wiendels NJ, "Chronic frequent headache in the general population:prevalence and associated factors", Cephalalgia, 26, pp.1434~1442 (2006)
- Russell MB, "Tension-type headache in 40-year-olds: a Danish population-based sample of 4000", J Headache Pain, 6, pp.441~447 (2005)